DCOY — Decoy Therapeutics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapSucker Stock

Annual balance sheet for Decoy Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	29.2	12.1	5.9	2.43	10.7
Net Total Accounts Receivable
Net Total Receivables	0	1.61	0	—	—
Prepaid Expenses
Total Current Assets	30.2	14.5	6.52	2.99	11
Net Property, Plant And Equipment	0.008	—	—	—	0.041
Net Goodwill
Long Term Notes Receivable
Other Long Term Assets
Total Assets	40.8	14.7	6.59	3.02	11.1
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	2.11	4.27	1.3	1.51	5.17
Total Long Term Debt
Total Debt
Total Liabilities	2.11	4.27	1.3	1.51	5.17
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	38.7	10.4	5.29	1.51	5.89
Total Liabilities & Shareholders' Equity	40.8	14.7	6.59	3.02	11.1
Total Common Shares Outstanding
Total Preferred Shares Outstanding